financetom
Personal Finance
financetom
/
Personal Finance
/
Research Alert: CFRA Keeps Strong Buy Opinion On Shares Of Arch Capital Group Ltd.
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Research Alert: CFRA Keeps Strong Buy Opinion On Shares Of Arch Capital Group Ltd.
May 26, 2025 12:45 AM

02:25 AM EDT, 05/03/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

We keep our 12-month target price of $110, valuing ACGL shares at 11x our 2026 operating EPS estimate of $9.90 and at 13.6x our 2025 EPS estimate of $8.06 (raised today by $0.56), vs. its one-year average forward multiple of 12x and a peer average of 14x. ACGL posted Q1 EPS of $1.54 vs. $2.45, topping our $0.48 EPS estimate and the $1.31 consensus view, as a 21% rise in operating revenues helped to offset the impact of $547 million of pretax California wildfire claims (vs. an earlier estimate of losses of between $550M and $650M). Despite this, underwriting results remained profitable, evidenced by the Q1 combined ratio of 90.1% vs. 78.8%. While we expect pricing for many lines of property coverage to become more competitive, we view ACGL as well positioned to outperform peers in this environment. Currently trading at 11x our 2025 EPS estimate and at 9.1x our 2026 EPS estimate, we view the shares as undervalued, and see above-peer growth and underwriting profitability metrics as catalysts for the shares.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Research Alert: CFRA Lowers Opinion On Lucid Group Inc. Shares To Strong Sell From Sell
Research Alert: CFRA Lowers Opinion On Lucid Group Inc. Shares To Strong Sell From Sell
Oct 7, 2025
08:20 AM EDT, 10/07/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We maintain our 12-month target of $10. We lower our adjusted EPS estimates to -$11.15 from -$10.50 for 2025 and to -$11.50 from -$11.00 for 2026. LCID posted Q3 vehicle...
Research Alert: CFRA Maintains Buy Opinion On Shares Of Constellation Brands Inc.
Research Alert: CFRA Maintains Buy Opinion On Shares Of Constellation Brands Inc.
Oct 7, 2025
11:50 AM EDT, 10/07/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We lower our 12-month target by $10 to $175, based on a 2027 P/E of 13.7x, a steep but justified discount to STZ's 10-year average forward P/E of 21.6x. We...
Research Alert: CFRA Raises Opinion On Health Care To Marketweight From Underweight
Research Alert: CFRA Raises Opinion On Health Care To Marketweight From Underweight
Oct 8, 2025
01:40 PM EDT, 10/08/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: After Pfizer Inc. (PFE 26 ****) and the U.S. government struck the first Most Favored Nation (MFN) drug pricing deal to lower drug prices in the U.S., we see policy...
Research Alert: CFRA Keeps Sell Opinion On Shares Of Mccormick & Company, Incorporated
Research Alert: CFRA Keeps Sell Opinion On Shares Of Mccormick & Company, Incorporated
Oct 7, 2025
02:30 PM EDT, 10/07/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We lower our 12-month target by $1 to $59, about 19x our FY 26 (Nov.) EPS estimate of $3.12 (down from $3.14; FY 25 raised to $3.03 from $2.97). This...
Copyright 2023-2025 - www.financetom.com All Rights Reserved